Success Story: Our Firm Helped a Biosciences Researcher Secure NIW Approval Without an RFE
Client’s Testimonial:
"I appreciate your kind advice and helping for the document preparation!”
On June 25th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Research Affiliate in the Field of Biosciences (Approval Notice).
General Field: Biosciences
Position at the Time of Case Filing: Research Affiliate
Country of Origin: China
State of Residence at the Time of Filing: New York
Approval Notice Date: June 25th, 2026
Processing Time: 20 months, 14 days (Premium Processing Upgrade Requested)
Case Summary:
We recently secured an I-140 National Interest Waiver (NIW) approval for a client working in the field of biosciences. The client’s work focuses on understanding the mechanisms and immune checkpoints of hematological malignancies, with the goal of developing more effective therapeutic strategies for cancer patients.
At the time of filing, the client was employed as a research affiliate at a cancer research center, where the client continued research involving blood cancer mechanisms, cancer models, and microbe-based approaches for delivering treatment substrates. This work closely aligned with the proposed endeavor and helped show a clear path for continued contributions in the United States.
Key Credentials Presented
- Ph.D. in comparative biomedical sciences
- 11 peer-reviewed journal articles, including 2 first-authored articles
- 1 abstract
- 175 citations to the client’s published work
- At least 30 completed peer reviews
- Research funding support from the National Institutes of Health (NIH) and the Congressionally Directed Medical Research Programs
Research Focus and National Importance
The client’s proposed endeavor was to continue research on deciphering the mechanisms and immune checkpoints of hematological malignancies using cell biology, molecular biology, immunology, microbiology, and single-cell analysis. The goal of this work is to support the development of effective therapeutic strategies, including novel medicine combinations and microbe-based immunotherapies for cancer patients.
In the petition, we explained that this research addresses a major public health concern because improved understanding of blood cancer mechanisms can help advance treatment strategies for patients facing serious hematological diseases. Rather than presenting the client’s work as a general cancer research effort, we connected the client’s specific expertise in immune regulation, cancer models, and microbial mechanisms to the broader need for improved cancer therapies.
In addition, the petition included 4 recommendation letters from experts in the field. These letters helped explain the technical significance of the client’s research and supported the conclusion that the client was well positioned to continue advancing cancer-related biosciences research in the United States. One expert stated that:
“Major journals such as these only invite top-tier experts in the field to review and judge the work of their peers, clearly signifying that [Client] is seen as an authority in the field of biosciences.”
Case Outcome
By organizing the evidence around the client’s specialized research, publication record, citation impact, peer-review activity, funding support, and expert recommendations, we demonstrated that the client’s work had substantial merit and national importance. We also showed that the client’s background and achievements supported continued progress in developing therapeutic strategies for cancer patients.
USCIS approved the client’s I-140 NIW petition, marking an important milestone in the client’s continued work in biosciences.